logo

For the Inventor, By the Inventor

Minoo, Japan

Tetsuo Tomishi

This inventor holds 5 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1994-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuo Tomishi. Retrieved from https://idiyas.com/inventor/tetsuo-tomishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal5 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1994-1996

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5532258 - H.sub.2 -receptor antagonist thiazoles (1996-07-02),
2. 5512588 - Furylthiazoles and their use as H.sub.2 - receptor antagonists and (1996-04-30),
3. 5371097 - Thiazole derivatives, processes for the preparation thereof and (1994-12-06),
4. 5364871 - New thiazole derivatives, and pharmaceutical composition comprising the (1994-11-15),
5. 5308857 - Furylthiazole derivatives, processes for the preparation thereof and (1994-05-03),

Title: Tetsuo Tomishi: Innovator in Pharmaceutical Chemistry

Introduction

Tetsuo Tomishi is a notable inventor based in Minoo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antiulcer activity. With a total of 5 patents to his name, Tomishi's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Tetsuo Tomishi has developed H₂-receptor antagonist thiazoles. These thiazole compounds exhibit antiulcer activity and H₂-receptor antagonism. The compounds are characterized by specific structural formulas, where R² represents lower alkyl or lower alkoxy(lower)alkyl, R³ is hydrogen, A is methylene, and R¹ is lower alkyl. His innovative work with furylthiazoles further emphasizes their use as H₂-receptor antagonists.

Career Highlights

Tetsuo Tomishi is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to advance his research and development efforts. His career has been marked by a commitment to improving therapeutic options for patients suffering from various ailments.

Collaborations

Throughout his career, Tomishi has collaborated with esteemed colleagues, including Yousuke Katsura and Yoshikazu Inoue. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Tetsuo Tomishi's contributions to pharmaceutical chemistry, particularly through his patents and collaborations, highlight his role as a key innovator in the field. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…